- Home
- NVS vs ISRG Comparison
NVS vs ISRG Comparison
Compare NVS & ISRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVS
- ISRG
- Stock Information
- Founded
- NVS 1895
- ISRG 1995
- Country
- NVS Switzerland
- ISRG United States
- Employees
- NVS N/A
- ISRG N/A
- Industry
- NVS Biotechnology: Pharmaceutical Preparations
- ISRG Medical/Dental Instruments
- Sector
- NVS Health Care
- ISRG Health Care
- Exchange
- NVS Nasdaq
- ISRG Nasdaq
- Market Cap
- NVS 230.5B
- ISRG 208.0B
- IPO Year
- NVS 1991
- ISRG 2000
- Fundamental
- Price
- NVS $109.37
- ISRG $591.79
- Analyst Decision
- NVS Hold
- ISRG Strong Buy
- Analyst Count
- NVS 6
- ISRG 19
- Target Price
- NVS $123.67
- ISRG $578.94
- AVG Volume (30 Days)
- NVS 2.1M
- ISRG 1.6M
- Earning Date
- NVS 01-31-2025
- ISRG 04-17-2025
- Dividend Yield
- NVS 3.44%
- ISRG N/A
- EPS Growth
- NVS N/A
- ISRG 27.63
- EPS
- NVS 5.87
- ISRG 6.42
- Revenue
- NVS $51,722,000,000.00
- ISRG $8,352,100,000.00
- Revenue This Year
- NVS $3.52
- ISRG $17.04
- Revenue Next Year
- NVS $2.10
- ISRG $15.63
- P/E Ratio
- NVS $18.05
- ISRG $92.18
- Revenue Growth
- NVS 10.85
- ISRG 17.24
- 52 Week Low
- NVS $92.35
- ISRG $364.17
- 52 Week High
- NVS $120.92
- ISRG $616.00
- Technical
- Relative Strength Index (RSI)
- NVS 64.90
- ISRG 54.67
- Support Level
- NVS $106.10
- ISRG $586.61
- Resistance Level
- NVS $108.09
- ISRG $609.08
- Average True Range (ATR)
- NVS 1.39
- ISRG 11.67
- MACD
- NVS 0.06
- ISRG -0.30
- Stochastic Oscillator
- NVS 88.19
- ISRG 62.26
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
About ISRG Intuitive Surgical Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.